SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-08-069293
Filing Date
2008-11-07
Accepted
2008-11-07 17:26:04
Documents
14
Period of Report
2008-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a08-25816_110q.htm 10-Q 1245906
2 EX-10.3 a08-25816_1ex10d3.htm EX-10.3 59696
3 EX-10.4 a08-25816_1ex10d4.htm EX-10.4 22482
4 EX-10.5 a08-25816_1ex10d5.htm EX-10.5 21262
5 EX-10.6 a08-25816_1ex10d6.htm EX-10.6 21157
6 EX-10.7 a08-25816_1ex10d7.htm EX-10.7 686142
7 EX-31.1 a08-25816_1ex31d1.htm EX-31.1 10147
8 EX-31.2 a08-25816_1ex31d2.htm EX-31.2 10656
9 EX-32.1 a08-25816_1ex32d1.htm EX-32.1 7572
10 GRAPHIC g258161bai001.jpg GRAPHIC 10312
11 GRAPHIC g258161kii001.jpg GRAPHIC 3134
12 GRAPHIC g258161kmi001.jpg GRAPHIC 3134
13 GRAPHIC g258161kgi001.jpg GRAPHIC 2843
14 GRAPHIC g258161kki001.jpg GRAPHIC 3134
  Complete submission text file 0001104659-08-069293.txt   2118362
Mailing Address 1400 SEAPORT BLVD. REDWOOD CITY CA 94063
Business Address 1400 SEAPORT BLVD. REDWOOD CITY CA 94063 650-454-1000
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19756 | Film No.: 081172698
SIC: 2836 Biological Products, (No Diagnostic Substances)